We are live on ! Find out more
EBACU

European Biotech Acquisition Corp. Units
EBACU

Delisted

EBACU was delisted on the 2nd of March, 2023.

Back to rankings

26 hedge funds and large institutions have $23.2M invested in European Biotech Acquisition Corp. Units in 2021 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less funds holding

Funds holding: 30 → 26 (-4)

17% less repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 6

27% less capital invested

Capital invested by funds: $31.6M → $23.2M (-$8.37M)

57% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 7

Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.4%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
5
Reduced
6
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
PMAM
Picton Mahoney Asset Management
Ontario, Canada
+$1.49M
2
CSS
Cubist Systematic Strategies
Connecticut
+$107K
3
FTCM
First Trust Capital Management
Illinois
+$99.1K
4
SMA
Sage Mountain Advisors
Georgia
+$18.4K
5
WAM
Wolverine Asset Management
Illinois
+$9.92K

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$4.62M
2
PCM
Pentwater Capital Management
Florida
-$1.49M
3
AMH
Apollo Management Holdings
New York
-$992K
4
SSA
Schonfeld Strategic Advisors
New York
-$888K
5
KSCM
King Street Capital Management
New York
-$496K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Pentwater Capital Management
Florida
– -$1.49M -150,000 Closed
AMH
27
Apollo Management Holdings
New York
– -$992K -99,791 Closed
SSA
28
Schonfeld Strategic Advisors
New York
– -$888K -89,475 Closed
KSCM
29
King Street Capital Management
New York
– -$496K -50,000 Closed
DIG
30
DeepCurrents Investment Group
New York
– -$176K -17,730 Closed
VCM
31
Vivaldi Capital Management
Illinois
– -$99K -10,000 Closed
1
2

EBACU Hedge Fund Activity: Q4 2021 in Review

26 of the 6,499 institutional investors tracked by Wall St. Rank reported a position in European Biotech Acquisition Corp. Units (EBACU) for Q4 2021, worth a combined $23.2M — down 27% from $31.6M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of EBACU and 3 opened new positions — a net loss of 4 holders — while 6 trimmed existing stakes and 5 added.

The largest buyer was Picton Mahoney Asset Management, adding an estimated $1.49M. The largest seller was Periscope Capital, exiting entirely with an estimated $4.62M sold.

  • 26 institutional investors held European Biotech Acquisition Corp. Units (EBACU) as of Q4 2021, down from 30 in Q3 2021.
  • Funds reported $23.2M of European Biotech Acquisition Corp. Units stock for Q4 2021, down 27% quarter-over-quarter.
  • 3 funds opened new European Biotech Acquisition Corp. Units positions in Q4 2021 and 7 closed out, a net change of -4 holders.
  • The largest European Biotech Acquisition Corp. Units buyer in Q4 2021 was Picton Mahoney Asset Management, an estimated $1.49M added.
  • The largest European Biotech Acquisition Corp. Units seller in Q4 2021 was Periscope Capital, an estimated $4.62M sold.

Based on aggregated 13F filings for Q4 2021.